Current challenges to primary liver cancer research
10.3969/j.issn.1001-5256.2015.06.001
- VernacularTitle:原发性肝癌研究当前面临的挑战
- Author:
Shenglong YE
1
Author Information
1. Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China)
- Publication Type:Research Article
- Keywords:
liver neoplasms;
diagnosis;
antineoplastic protocols;
editorial
- From:
Journal of Clinical Hepatology
2015;31(6):819-
- CountryChina
- Language:Chinese
-
Abstract:
Primary liver cancer is a common malignancy with increasing incidence and mortality. Remarkable progress has been made in the clinical research on liver cancer, but challenges to further improvement are still rigorous. This article reviews the progress and difficulties of primary liver cancer study from the following aspects: molecular classification and stem cell biology, pathological and clinical diagnosis, clinical staging, surgical treatment, loco-regional treatment, molecular targeted therapy, systemic chemotherapy, management of portal vein tumor thrombus, antiviral therapy, diagnosis and treatment of intrahepatic cholangiocarcinoma, and multimodality treatment. The future strategies to further improve primary liver cancer study are also investigated.
